lantern pharma (nasdaq: ltrn): a.i. & genomics revolutionizing oncology drug development
Published 7 months ago • 9.6K plays • Length 0:31Download video MP4
Download video MP3
Similar videos
-
1:55
lantern pharma: using ai to transform drug development
-
0:17
lantern pharma: redefining oncology drug development with a.i. and machine learning
-
0:18
lantern pharma: redefining oncology drug development with a.i. and machine learning
-
49:16
creating an ai-driven biotech for cancer drug development | panna sharma | nasdaq: ltrn
-
6:10
lantern pharma's ai-based drug discovery and development targeting cancer
-
7:19
how ai is accelerating advancements in oncology | nasdaq breakthrough economy | lantern pharma
-
6:46
nad precursor nmn - using nmn to improve nad levels along with sirt1 activation
-
10:23
[ltrn webinar] lp-300 in never smokers with non-small cell lung cancer with dr. treat from fccc
-
10:00
[ltrn webinar] - lp-184 in pancreatic cancer and other solid tumors with dr. igor from fccc
-
31:08
[ltrn webinar] lantern pharma webinar wednesdays - childhood cancer awareness month
-
2:54
the science behind lantern pharma's cancer drug development
-
37:36
lantern pharma (ltrn) "how ai has lit a revolution in healthcare, medicine, & human longevity"
-
0:55
what is lantern pharma's radr™ system, and how does it help with cancer drug development?
-
5:44
lantern pharma is using artificial intelligence to develop oncology treatments
-
0:31
artificial intelligence and machine learning in precision medicine - lantern pharma
-
27:05
think equity conference 2023 | overview of lantern pharma inc. (nasdaq: ltrn) by panna sharma
-
45:39
lantern (ltrn) "how artificial intelligence is crushing drug discovery times & costs in cancer"
-
0:26
drug facts - lantern pharma collaboration [may 2023]
-
0:50
“the buzz'' show: lantern pharma (nasdaq: ltrn) positive cancer collaboration data
-
4:15
how ai is accelerating drug discovery - nature's building blocks | bbc storyworks